Image-guided Devices

Develop integrated clinical decision support for anomaly detection, malignancy determination, tumor characterization and margin assessment.


Support efficient cancer drug development with new imaging biomarkers appropriate for modern clinical trial endpoints.

Partner for the co-development of Companion Diagnostic.

Liquid Biopsy

Trigger and justify increased use of test.
Complement test to improve sensitivity and specificity.